Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-110846
Filing Date
2025-11-13
Accepted
2025-11-13 07:30:54
Documents
55
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgmt-20250930x10q.htm   iXBRL 10-Q 1695924
2 EX-31.1 sgmt-20250930xex31d1.htm EX-31.1 13071
3 EX-31.2 sgmt-20250930xex31d2.htm EX-31.2 14039
4 EX-32.1 sgmt-20250930xex32d1.htm EX-32.1 9776
  Complete submission text file 0001104659-25-110846.txt   6723313

Data Files

Seq Description Document Type Size
5 EX-101.SCH sgmt-20250930.xsd EX-101.SCH 28043
6 EX-101.CAL sgmt-20250930_cal.xml EX-101.CAL 32516
7 EX-101.DEF sgmt-20250930_def.xml EX-101.DEF 169244
8 EX-101.LAB sgmt-20250930_lab.xml EX-101.LAB 336566
9 EX-101.PRE sgmt-20250930_pre.xml EX-101.PRE 254629
58 EXTRACTED XBRL INSTANCE DOCUMENT sgmt-20250930x10q_htm.xml XML 1353294
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41742 | Film No.: 251475411
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)